Literature DB >> 30245648

Psychedelics, Meditation, and Self-Consciousness.

Raphaël Millière1, Robin L Carhart-Harris2, Leor Roseman2, Fynn-Mathis Trautwein3, Aviva Berkovich-Ohana4.   

Abstract

In recent years, the scientific study of meditation and psychedelic drugs has seen remarkable developments. The increased focus on meditation in cognitive neuroscience has led to a cross-cultural classification of standard meditation styles validated by functional and structural neuroanatomical data. Meanwhile, the renaissance of psychedelic research has shed light on the neurophysiology of altered states of consciousness induced by classical psychedelics, such as psilocybin and LSD, whose effects are mainly mediated by agonism of serotonin receptors. Few attempts have been made at bridging these two domains of inquiry, despite intriguing evidence of overlap between the phenomenology and neurophysiology of meditation practice and psychedelic states. In particular, many contemplative traditions explicitly aim at dissolving the sense of self by eliciting altered states of consciousness through meditation, while classical psychedelics are known to produce significant disruptions of self-consciousness, a phenomenon known as drug-induced ego dissolution. In this article, we discuss available evidence regarding convergences and differences between phenomenological and neurophysiological data on meditation practice and psychedelic drug-induced states, with a particular emphasis on alterations of self-experience. While both meditation and psychedelics may disrupt self-consciousness and underlying neural processes, we emphasize that neither meditation nor psychedelic states can be conceived as simple, uniform categories. Moreover, we suggest that there are important phenomenological differences even between conscious states described as experiences of self-loss. As a result, we propose that self-consciousness may be best construed as a multidimensional construct, and that "self-loss," far from being an unequivocal phenomenon, can take several forms. Indeed, various aspects of self-consciousness, including narrative aspects linked to autobiographical memory, self-related thoughts and mental time travel, and embodied aspects rooted in multisensory processes, may be differently affected by psychedelics and meditation practices. Finally, we consider long-term outcomes of experiences of self-loss induced by meditation and psychedelics on individual traits and prosocial behavior. We call for caution regarding the problematic conflation of temporary states of self-loss with "selflessness" as a behavioral or social trait, although there is preliminary evidence that correlations between short-term experiences of self-loss and long-term trait alterations may exist.

Entities:  

Keywords:  autobiographical memory; bodily self-consciousness; consciousness; meditation; mental time travel; mind wandering; psychedelics; self-consciousness

Year:  2018        PMID: 30245648      PMCID: PMC6137697          DOI: 10.3389/fpsyg.2018.01475

Source DB:  PubMed          Journal:  Front Psychol        ISSN: 1664-1078


  221 in total

1.  Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

Authors:  Katherine A MacLean; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2011-09-28       Impact factor: 4.153

2.  Multisensory integration across exteroceptive and interoceptive domains modulates self-experience in the rubber-hand illusion.

Authors:  Keisuke Suzuki; Sarah N Garfinkel; Hugo D Critchley; Anil K Seth
Journal:  Neuropsychologia       Date:  2013-08-28       Impact factor: 3.139

3.  The experimental induction of out-of-body experiences.

Authors:  H Henrik Ehrsson
Journal:  Science       Date:  2007-08-24       Impact factor: 47.728

4.  Mescalin and Depersonalization: Therapeutic Experiments.

Authors:  E Guttmann; W S Maclay
Journal:  J Neurol Psychopathol       Date:  1936-01

5.  Dynamical properties of BOLD activity from the ventral posteromedial cortex associated with meditation and attentional skills.

Authors:  Giuseppe Pagnoni
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

6.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

Review 7.  The free-energy self: a predictive coding account of self-recognition.

Authors:  Matthew A J Apps; Manos Tsakiris
Journal:  Neurosci Biobehav Rev       Date:  2013-02-15       Impact factor: 8.989

Review 8.  Active interoceptive inference and the emotional brain.

Authors:  Anil K Seth; Karl J Friston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-10-10       Impact factor: 6.237

9.  Broadband cortical desynchronization underlies the human psychedelic state.

Authors:  Suresh D Muthukumaraswamy; Robin L Carhart-Harris; Rosalyn J Moran; Matthew J Brookes; Tim M Williams; David Errtizoe; Ben Sessa; Andreas Papadopoulos; Mark Bolstridge; Krish D Singh; Amanda Feilding; Karl J Friston; David J Nutt
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

10.  Alterations in the sense of time, space, and body in the mindfulness-trained brain: a neurophenomenologically-guided MEG study.

Authors:  Aviva Berkovich-Ohana; Yair Dor-Ziderman; Joseph Glicksohn; Abraham Goldstein
Journal:  Front Psychol       Date:  2013-12-03
View more
  31 in total

Review 1.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Self, Me and I in the repertoire of spontaneously occurring altered states of Selfhood: eight neurophenomenological case study reports.

Authors:  Andrew A Fingelkurts; Alexander A Fingelkurts; Tarja Kallio-Tamminen
Journal:  Cogn Neurodyn       Date:  2021-09-17       Impact factor: 5.082

Review 3.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

Review 4.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

5.  Models of psychedelic drug action: modulation of cortical-subcortical circuits.

Authors:  Manoj K Doss; Maxwell B Madden; Andrew Gaddis; Mary Beth Nebel; Roland R Griffiths; Brian N Mathur; Frederick S Barrett
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

Review 6.  Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice.

Authors:  Jake E Payne; Richard Chambers; Paul Liknaitzky
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-16

7.  Effects of Mindfulness Meditation on Self-Transcendent States: Perceived Body Boundaries and Spatial Frames of Reference.

Authors:  Adam W Hanley; Michael Dambrun; Eric L Garland
Journal:  Mindfulness (N Y)       Date:  2020-02-14

8.  Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.

Authors:  C J Healy; Kellie Ann Lee; Wendy D'Andrea
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-07-11

9.  Meditation-induced effects on whole-brain structural and effective connectivity.

Authors:  Eleonora De Filippi; Anira Escrichs; Estela Càmara; César Garrido; Theo Marins; Marti Sánchez-Fibla; Matthieu Gilson; Gustavo Deco
Journal:  Brain Struct Funct       Date:  2022-05-06       Impact factor: 3.748

10.  How Action Shapes Body Ownership Momentarily and Throughout the Lifespan.

Authors:  Marvin Liesner; Nina-Alisa Hinz; Wilfried Kunde
Journal:  Front Hum Neurosci       Date:  2021-07-06       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.